Stay updated on Uproleselan Combo in R/R AML Chinese Patients Clinical Trial
Sign up to get notified when there's something new on the Uproleselan Combo in R/R AML Chinese Patients Clinical Trial page.

Latest updates to the Uproleselan Combo in R/R AML Chinese Patients Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page history shows a new revision entry v3.3.2 and removal of v3.3.1, which are minor updates to the historical record.SummaryDifference0.1%

- Check21 days agoChange DetectedA new revision entry v3.3.1 was added to the history, and revision v3.2.0 was removed. This is metadata about the page's revision history rather than substantive study details.SummaryDifference0.1%

- Check29 days agoChange DetectedThe warning notice about government funding was removed from the top of the page. This change removes a site-wide operating-status notice that previously appeared.SummaryDifference0.8%

- Check43 days agoChange DetectedThe Record History shows two recruitment-status updates (2021-11-22 and 2025-06-24), with the 2025 version including a termination notice and related study detail revisions.SummaryDifference0.1%

- Check71 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference13%

- Check79 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.3%

Stay in the know with updates to Uproleselan Combo in R/R AML Chinese Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Uproleselan Combo in R/R AML Chinese Patients Clinical Trial page.